Rytus Therapeutics Limited - Company Profile

It is a pharma public limited company based in Thane, Maharashtra, India, established in 2011.
2011 Thane, Maharashtra, India Under Cirp
Last Updated:
Access Report
About Rytus Therapeutics Limited

Rytus Therapeutics Limited, a under cirp public limited company, was established on 21 February 2011 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2011PLC213828. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.25 Cr and a paid-up capital of ₹6.21 Cr.

It upholds a compliant status. Its leadership includes Anand Mohanty Swaroop (Whole-Time Director), Atul Laxmichand Gala (Irp/Rp/Liquidator), Abhinna Mohanty Sundar (Director). Past directors included Anand Mohanty Swaroop, Supriya Mohanty, Akhilesh Dayanand Sharma. It holds no open charges and ₹1.85 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Flat No.1601, 16Th Floor, Willowcrest Building One Hiranandani Park, Ghodbunder Road,Th, Ane West, Thane, Maharashtra, 400607.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2011PLC213828

  • Registration Number

    213828

  • Incorporation Date

    21 February 2011

  • Authorized Capital

    ₹6.25 Cr

  • Paid-Up Capital

    ₹6.21 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Under Cirp

Key Metrics
  • Authorised Capital ₹ 6.25 Cr
  • Paid Up Capital ₹ 6.21 Cr
  • Company Age 14 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 1.85 Cr
  • Revenue Growth **** 62.76%
  • Profit Growth **** 35.29%
  • Ebitda **** 49.11%
  • Net Worth -251.16%
  • Total Assets -20.30%
Company report

Rytus Therapeutics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rytus Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rytus Therapeutics Limited?
Current Directors
Name Designation Appointment Date Status
Anand Mohanty Swaroop Whole-Time Director 21 Feb 2011 Current
Atul Laxmichand Gala Irp/Rp/Liquidator 24 Jun 2024 Current
Abhinna Mohanty Sundar Director 21 Feb 2011 Current
Manas Ranjan Patnaik Additional Director 01 Dec 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Apr 2011 Past
Pramod Abcsdd Director 01 Dec 2021 Past
Pramod Abcsdd Whole-Time Director 11 Apr 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rytus Therapeutics.

Rytus Therapeutics Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 62.76% increase. The company also saw a substantial improvement in profitability, with a 35.29% increase in profit. The company's net worth observed a substantial decline by a decrease of 251.16%.

Rytus Therapeutics revenue growth over time
Rytus Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 62.76%
*******
*******
*******
*******
Revenue from Operations
*******
 35.71%
*******
*******
*******
*******
Total Assets
*******
 -20.30%
*******
*******
*******
*******
Profit or Loss
*******
 35.29%
*******
*******
*******
*******
Net Worth
*******
 -251.16%
*******
*******
*******
*******
EBITDA
*******
 49.11%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rytus Therapeutics?

In 2015, Rytus Therapeutics had a promoter holding of 41.43% and a public holding of 58.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹18,500,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 1.10 Cr
  • Tamilnad Mercantile Bank Limited : 0.75 Cr
Latest Charge Details
Date Lender Amount Status
26 Feb 2013 Axis Bank Limited ₹1.10 Cr Satisfied
05 Oct 2011 Tamilnad Mercantile Bank Limited ₹7.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rytus Therapeutics?

Unlock and access historical data on people associated with Rytus Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rytus Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rytus Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rytus Therapeutics
Recent Activity within the Organization
  • Director Appointment

    The activity Atul Laxmichand Gala was appointed as a IRP/RP/Liquidator was appointed as a IRP/RP/Liquidator on 24 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Annual General Meeting

    Rytus Therapeutics Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Rytus Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Manas Ranjan Patnaik was appointed as a Additional Director was appointed as a Additional Director on 01 Dec 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.

  • Charges

    Progress on A charge registered on 26 Feb 2013 via Charge ID 10408148 with Axis Bank Limited was fully satisfied on 16 Dec 2013. was documented.

  • Charges

    A charge with Axis Bank Limited of Rs. 1.10 Cr registered on 26 Feb 2013 with Charge ID 10408148 was modified on 09 Oct 2013. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rytus Therapeutics Limited?

The CIN of Rytus Therapeutics Limited is U24100MH2011PLC213828.

Where is Rytus Therapeutics Limited headquartered?

Rytus Therapeutics Limited is headquartered at Flat No.1601, 16Th Floor, Willowcrest Building One Hiranandani Park, Ghodbunder Road,Th, Ane West, Thane, Maharashtra, 400607.

When was Rytus Therapeutics Limited incorporated?

Rytus Therapeutics Limited was incorporated on 21 February 2011.

Who are the current directors of Rytus Therapeutics Limited?

The current directors of Rytus Therapeutics Limited are

What is the primary industry of Rytus Therapeutics Limited?

The primary industry of Rytus Therapeutics Limited is Trade.

Is Rytus Therapeutics Limited a listed company?

Rytus Therapeutics Limited is unlisted.

What is the capital structure of Rytus Therapeutics Limited?

The authorized capital of Rytus Therapeutics Limited is ₹6.25 Cr, and the paid-up capital is ₹6.21 Cr.

What is the compliance status of Rytus Therapeutics Limited?

The compliance status of Rytus Therapeutics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available